Overview

Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Male volunteers receive a new hormonal contraceptive consisting of an implant releasing a hormone and hormone injections in order to investigate the suppressive effect on sperm production and reversibility of sperm production after end of treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Collaborator:
Bayer
Treatments:
Desogestrel
Etonogestrel
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate